BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05646862-completion@plaintrial.com
DTSTAMP:20260926T124632Z
DTSTART;VALUE=DATE:20290330
SUMMARY:A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulve
 strant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Po
 sitive\, HER2-Negative\, PIK3CA Mutated\, Locally Advanced or Metastatic B
 reast Cancer Post CDK4/6i and Endocrine Combination Therapy — estimated 
 completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05646862
URL:https://plaintrial.com/trial/NCT05646862
END:VEVENT
END:VCALENDAR
